Company: SMNR
Filing Date: 2025-04-02
Form Type: 10-K
Source: 0001213900-25-027319
Chunk: 1048

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-02
Form: 10-K
Item: Item 7
Chunk 1048
---
 The number of shares held by the TD Reporting Persons is reported
                                            as of December 16, 2024, as stated in the Schedule 13G, which does not reflect any redemption
                                            of shares by the TD Reporting Persons in connection with the Business Combination itself,
                                            or any other transactions after December 16, 2024. The business address of such holder is
                                            One Vanderbilt Avenue, New York, New York 10017.

    (4)
    This information is based solely on a Schedule 13G/A filed by Meteora Capital, LLC and Vik Mittal (the “Meteora Reporting Persons”) with the SEC on February 7, 2025. The Meteora Reporting Persons have a shared voting power of 498,798 shares and shared dispositive power of 498,798 shares. The number of shares held by Meteora Reporting Persons is reported as of January 31, 2025, as stated in the Schedule 13G/A, which does not reflect any redemption of shares by the Meteora Reporting Persons in connection with extensions of the deadlines to complete the Business Combination or the Business Combination itself, or any other transactions after January 31, 2025. The business address of such holder is 1200 N Federal Hwy, #200, Boca Raton FL 33432.

(5)This
                                            information is based solely on a Schedule 13G filed by Mizuho Financial Group, Inc. (“Mizuho”)
                                            with the SEC on February 10, 2023. Mizuho has sole voting power of 493,672 shares and sole
                                            dispositive power of 493,672 shares. The number of shares held by Mizuho is reported as of
                                            December 31, 2022, as stated in the Schedule 13G, which does not reflect any redemption of
                                            shares by Mizuho in connection with extensions of the deadlines to complete the Business
                                            Combination or the Business Combination itself, or any other transactions after December
                                            31, 2022. The business address of such holder is 1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176,
                                            Japan.

29

As of April 1, 2025, our initial
shareholders beneficially owned approximately 47% of issued and outstanding ordinary shares and have the right to appoint all of our directors
prior to our initial business combination. Holders